Advertisement

Glenmark Receives ANDA Approval For Metronidazole Gel

The company's current portfolio consists of 173 products authorised for distribution in the US marketplace.

Glenmark Pharmaceuticals, USA has received final approval by the United States Food & Drug Administration (US FDA) for Metronidazole Vaginal Gel, 0.75 per cent, the generic version of MetroGel-Vaginal Gel, 0.75 per cent, of Bausch Health US, LLC.

According to IQVIATM sales data for the 12 month period ending November 2021, the MetroGel- Vaginal Gel, 0.75 per cent market achieved annual sales of approximately $60.4 million.

Glenmark’s current portfolio consists of 173 products authorised for distribution in the US marketplace and 46 ANDA’s pending approval with the US FDA. 


Tags assigned to this article:
glenmark ANDA approval Metronidazole Gel

Advertisement

Around The World